𝔖 Bobbio Scriptorium
✦   LIBER   ✦

β- And γ-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability

✍ Scribed by José Palacios; Lluis Catasús; Gema Moreno-Bueno; Xavier Matias-Guiu; Jaime Prat; Carlos Gamallo

Publisher
Springer
Year
2001
Tongue
English
Weight
233 KB
Volume
438
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Microsatellite instability and hMLH1/hMS
Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology
✍ Yann R. Parc; Kevin C. Halling; Larry J. Burgart; Shannon K. McDonnell; Daniel J 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 556 KB

Endometrial cancer is the second most common malignancy in patients with hereditary nonpolyposis colorectal cancer (HNPCC). The age at diagnosis of HNPCC-associated endometrial cancer is approximately 15 years younger than for sporadic endometrial cancer. Our current study was undertaken to determin

Expression of ps2 protein in endometrial
Expression of ps2 protein in endometrial carcinomas: Correlation with clinicopathologic features and sex steroid receptor status
✍ Masafumi Koshiyama; Masumi Yoshida; Mitsunaga Konishi; Maki Takemura; Yasuichiro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 529 KB

Using immunohistochemistry, we examined pS2 expression in 64 samples of endometrial carcinoma, 11 samples of endometrial hyperplasia and 15 samples of normal endometrium, and compared them with clinicopathological data, estrogen receptor (ER) expression and progesterone receptor (PR) expression. Of

Epigenetic and genetic alterations of AP
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability
✍ David Sarrió; Gema Moreno-Bueno; David Hardisson; Carolina Sánchez-Estévez; Ming 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

## Abstract The causes and functional consequences of E‐cadherin (E‐CD) loss in breast cancer are poorly understood. E‐CD loss might act in concert with alterations in the APC/β‐catenin pathway to permit oncogenic β‐catenin signaling. To test this hypothesis, we have analyzed the presence of geneti